Combivir
Combivir Price range: $ 86,00 through $ 513,00
Back to products
Confido
Confido Price range: $ 53,00 through $ 203,00

Compazine

Price range: $ 40,00 through $ 118,00

Compazine is a potent medication primarily utilized to control severe nausea and vomiting caused by various medical conditions. As a member of the phenothiazine class, it effectively targets the nervous system to provide rapid relief from persistent gastrointestinal distress. This versatile treatment is also indicated for the short-term management of non-psychotic anxiety in specific patient populations. Furthermore, it is officially recognized for its role in treating symptoms associated with schizophrenia and other psychotic disorders. By addressing both physical discomfort and psychological symptoms, Compazine helps restore stability and improves overall daily functioning.

Active substance: Prochlorperazine
SKU: Compazine Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Compazine belongs to a class of medications known as phenothiazines, primarily prescribed under federal regulations in the United States. It is indicated for managing severe nausea and vomiting, as well as providing short-term management of generalized non-psychotic anxiety in specific clinical settings.

Because this prescription agent carries significant pharmacological warnings, its administration requires strict clinical oversight. Understanding its underlying mechanism, risk profile, and essential precautions helps ensure patient safety throughout the duration of therapy.

Parameter Details
Active ingredient Prochlorperazine maleate / Prochlorperazine edisylate
Therapeutic class Phenothiazine antiemetic / Antipsychotic
Dosage form Oral tablet, rectal suppository, injectable solution
Route of administration Oral, rectal, intramuscular, intravenous
Primary purpose Control of severe nausea, vomiting, and non-psychotic anxiety
Prescription status Prescription (Rx) only

Safety Profile and Clinical Warnings

Important precautions
Compazine carries a Boxed Warning regarding its use in elderly patients with dementia-related psychosis. Clinical trials indicate that elderly patients treated with antipsychotic medications in this category face an increased risk of mortality. Compazine is not approved for treating dementia-related behavioral disorders. Furthermore, phenothiazine therapy can trigger Neuroleptic Malignant Syndrome (NMS), a potentially fatal complex characterized by hyperpyrexia, muscle rigidity, altered mental status, and autonomic instability. Another severe risk is Tardive Dyskinesia, a syndrome consisting of potentially irreversible, involuntary dyskinetic movements.

Red flags: When to seek help immediately
Certain adverse reactions require urgent emergency medical attention. Patients and caregivers must monitor continuously for signs of neuromuscular impairment, systemic toxicity, or severe hypersensitivity. Immediate action is critical if acute movement disorders or organ toxicity develop.

Emergency Warning Signs

Warning Sign Possible Underlying Condition
High fever, severe muscle stiffness, confusion, irregular heart rate Neuroleptic Malignant Syndrome (NMS)
Involuntary lip smacking, tongue protrusion, or facial grimacing Tardive Dyskinesia
Swelling of the face, lips, tongue, or throat with breathing difficulty Severe allergic reaction (Anaphylaxis)
Yellowing of the skin or eyes (jaundice), dark urine Hepatic dysfunction / Liver toxicity
Sudden drop in blood pressure, severe dizziness, fainting spells Severe orthostatic hypotension

Immediate medical evaluation is necessary if a patient exhibits any of the symptoms listed above. Prompt intervention in an emergency department is vital to mitigate life-threatening complications associated with severe phenothiazine toxicity.

What to avoid while taking it
Concomitant consumption of alcohol must be strictly avoided due to additive central nervous system depression. Patients taking Compazine should avoid exposure to high environmental heat, hot tubs, or intense physical exertion. Phenothiazines impair the hypothalamic thermoregulatory center, significantly elevating the risk of heat stroke. Operating hazardous machinery or driving motor vehicles should be avoided until individual susceptibility to sedation is fully evaluated.

Compatibility with other medicines
Compazine interacts with multiple drug classes. Co-administration with central nervous system depressants–including opioid analgesics, barbiturates, sedatives, and general anesthetics–significantly enhances central depression and respiratory risk. Anticholinergic medications combined with phenothiazines increase the risk of severe constipation, paralytic ileus, and heat intolerance. Administering Compazine alongside drugs known to prolong the QT interval can precipitate dangerous cardiac arrhythmias. The therapeutic actions of oral anticoagulants or dopamine agonists such as levodopa may also be impaired.

Pharmacological Guidance and Practical Use

Main uses
Compazine is FDA-approved for controlling severe nausea and vomiting brought on by surgery, radiation therapy, chemotherapy, or underlying systemic illness. It is also indicated for the short-term treatment of generalized non-psychotic anxiety. In emergency medical settings, Compazine is sometimes administered off-label via intravenous infusion as part of standardized acute migraine treatment protocols. When prescribed off-label, dosage and administration follow institutional clinical guidelines.

How the drug works
The primary mechanism of action involves postsynaptic inhibition of dopamine D2 receptors in the chemoreceptor trigger zone (CTZ) of the medulla oblongata. Blockade of CTZ receptors prevents central signaling to the emetic center, curbing nausea and vomiting responses. In the limbic system, dopamine receptor blockade produces anxiolytic and psychotropic effects. Compazine also demonstrates mild anticholinergic, antihistaminic, and alpha-adrenergic blocking properties.

What happens in the body
Following oral administration of prochlorperazine maleate, absorption occurs via the gastrointestinal tract, achieving peak plasma levels within 1.5 to 3 hours. The compound undergoes extensive hepatic metabolism through cytochrome P450 pathways. Elimination occurs through both renal and biliary pathways. The elimination half-life varies among individuals, generally ranging between 6 and 9 hours depending on patient physiology and formulation type.

Dosing schedule
Dosing must be strictly determined by a licensed healthcare provider based on the indication, patient weight, age, and clinical response. Oral tablets and rectal suppositories are administered at specific interval schedules. In elderly or debilitated patients, lower initial doses are required to reduce the incidence of hypotension and neuromuscular adverse effects. Patients should strictly follow their prescriber’s schedule and never adjust doses independently.

Adverse reactions
Common adverse reactions associated with Compazine include somnolence, dizziness, dry mouth, blurred vision, nasal congestion, and amenorrhea. Neurological side effects are notable and include extrapyramidal symptoms such as akathisia (motor restlessness), acute dystonia (painful muscle contractions of the neck, jaw, or eyes), and pseudoparkinsonism. Hypotension, particularly orthostatic hypotension, may occur following administration.

Special populations
Compazine is contraindicated in pediatric patients under 2 years of age or weighing less than 20 pounds due to heightened vulnerability to severe dystonic reactions. During pregnancy, it should be used only if the potential benefit justifies potential fetal risk; infants exposed to phenothiazines during the third trimester face risks of extrapyramidal and withdrawal symptoms post-delivery. Nursing mothers should consult their physician, as prochlorperazine is excreted in human milk. Elderly patients require lower starting doses due to reduced metabolic clearance and increased sensitivity to adverse neurological and cardiovascular events.

If you skip a dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. Patients should never double up on doses to make up for a missed application.

Frequently Asked Questions

What should I do if I experience sudden muscle spasms or involuntary restlessness after taking Compazine?
Sudden muscle contractions, particularly in the neck, jaw, or eyes, or an uncontrollable internal urge to move are signs of extrapyramidal side effects. You should contact your healthcare provider or seek emergency medical evaluation immediately, as these reactions often require prompt corrective treatment.

Can Compazine cause severe drowsiness that affects daily activities?
Yes, central nervous system depression causing significant drowsiness, lethargy, and slowed motor reflexes is a common effect of Compazine. You should refrain from driving, operating machinery, or performing tasks requiring high mental alertness until you know how the medication affects you.

Why is there a specific warning for elderly individuals with dementia?
Clinical evidence shows that elderly patients with dementia-related psychosis treated with antipsychotic agents, including phenothiazines like Compazine, face an increased mortality risk compared to placebo. Because of this risk, Compazine is not approved for managing dementia-related behavioral disorders.

How does Compazine interact with high environmental temperatures?
Compazine suppresses the temperature-regulating center in the brain, impairing the body’s natural ability to sweat and dissipate heat. Exposure to severe environmental heat or engaging in heavy physical exertion while taking this drug increases the risk of heat stroke.

Is it safe to stop taking Compazine suddenly after prolonged use?
Abruptly stopping prochlorperazine after extended use can trigger withdrawal symptoms such as acute nausea, vomiting, dizziness, and tremors. Tapering schedules should always be supervised directly by a prescribing physician.

Important Notice

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

5mg

Package

90 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία